Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-12 Purchase |
2024-08-13 4:15 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
4,515 | $2.2474 | $10,147 | 138,359 (Indirect Direct) |
View |
| 2024-08-09 Purchase |
2024-08-12 6:28 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
4,285 | $2.365 | $10,134 | 133,844 (Indirect Direct) |
View |
| 2024-05-10 Purchase |
2024-05-10 4:04 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
5,400 | $1.91 | $10,314 | 79,559 (Indirect Direct) |
View |
| 2024-03-22 Purchase |
2024-03-25 7:10 pm |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
26,965 | $3.6988 | $99,738 | 57,639 (Indirect Direct) |
View |
| 2024-03-14 Purchase |
2024-03-14 9:03 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
4,500 | $2.16 | $9,720 | 74,159 (Indirect Direct) |
View |
| 2023-11-16 Purchase |
2023-11-17 6:35 pm |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
6,500 | $1.51 | $9,815 | 69,659 (Indirect Direct) |
View |
| 2021-10-05 Sale |
2021-10-05 5:37 pm |
XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director |
5,659 | $0 | $0 | 0 (Direct) |
View |
| 2021-03-19 Sale |
2021-03-19 5:33 pm |
Neos Therapeutics Inc. | NEOS | Schmid John P. Director |
23,453 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-25 Other |
2025-03-27 4:10 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
11,068 | $18.18 | 68,373 (Indirect) |
View |
| 2025-01-13 Exercise |
2025-01-15 5:04 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
20,645 | $8.54 | 46,237 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 5:04 pm |
N/A 2025-06-09 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
42,337 | $0 | 46,237 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 5:04 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
21,692 | $4.55 | 46,237 (Direct) |
View |
| 2025-01-08 Equity Swap |
2025-01-08 2:16 pm |
N/A N/A |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
58,950 | $0 | 0 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-07 5:28 pm |
N/A 2035-01-06 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
22,540 | $0 | 22,540 (Direct) |
View |
| 2024-06-15 Exercise |
2024-06-18 8:17 pm |
N/A N/A |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
3,900 | $0 | 3,900 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:16 pm |
N/A 2034-06-16 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
47,000 | $0 | 86,300 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
19,000 | $0 | 19,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-05 4:19 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
50,000 | $0 | 129,559 (Direct) |
View |
Ownership |
2024-02-09 06:13 am |
N/A N/A |
Helix Acquisition Corp. II | HLXB | Schmid John P. Director |
0 | $0 | 30,000 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:58 pm |
N/A 2034-01-02 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
22,540 | $0 | 22,540 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-16 4:09 pm |
N/A 2033-06-14 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
47,000 | $0 | 66,650 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-07 4:55 pm |
N/A N/A |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
42,500 | $0 | 63,159 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-10 7:11 pm |
N/A 2033-01-05 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-16 8:56 pm |
N/A 2032-06-15 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
48,150 | $0 | 48,150 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-16 5:10 pm |
N/A 2032-06-14 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-09 5:13 pm |
2022-06-08 2032-06-08 |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
40,000 | $0 | 45,659 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 4:50 pm |
N/A 2032-02-09 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
9,200 | $0 | 9,200 (Direct) |
View |
| 2021-10-05 Option Award |
2021-10-05 7:41 pm |
N/A 2028-05-15 |
Xeris Biopharma Holdings Inc. | XERS | Schmid John P. Director |
73,335 | $0 | 73,335 (Direct) |
View |
| 2021-07-23 Option Award |
2021-07-26 8:32 pm |
N/A 2031-07-23 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
25,833 | $0 | 25,833 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 5:03 pm |
N/A 2031-06-15 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-08 7:08 pm |
N/A 2031-06-08 |
XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director |
11,228 | $0 | 11,228 (Direct) |
View |
| 2021-03-25 Option Award |
2021-03-29 5:55 pm |
N/A 2031-03-24 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2021-03-25 9:08 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
0 | $0 | 30,674 (Direct) |
View |
| 2021-02-10 Option Award |
2021-02-12 9:36 pm |
N/A 2031-02-09 |
ANAPTYSBIO INC | ANAB | Schmid John P. Director |
11,000 | $0 | 11,000 (Direct) |
View |
Ownership |
2020-10-19 9:08 pm |
N/A N/A |
Helix Acquisition Corp | HLXA | Schmid John P. Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-07-09 Option Award |
2020-07-13 7:00 pm |
N/A 2030-07-08 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-07-09 6:00 pm |
N/A 2028-07-16 |
Poseida Therapeutics Inc. | PSTX | Schmid John P. Director |
0 | $0 | 48,114 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-11 8:24 pm |
N/A N/A |
Neos Therapeutics Inc. | NEOS | Schmid John P. Director |
23,453 | $0 | 23,453 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-04 9:02 pm |
N/A 2030-06-04 |
XERIS PHARMACEUTICALS INC | XERS | Schmid John P. Director |
11,228 | $0 | 11,228 (Direct) |
View |